M K Brenner Selected Research

M K Brenner Research Topics

Disease

22	Neoplasms (Cancer) 06/2013 - 12/2000
4	Lymphoma (Lymphomas) 06/2010 - 02/2000
4	Neuroblastoma 01/2009 - 07/2000
3	Leukemia 06/2010 - 08/2001
3	Hodgkin Disease (Hodgkin's Disease) 04/2010 - 09/2001
2	Infections 02/2014 - 11/2005
2	Prostatic Neoplasms (Prostate Cancer) 06/2013 - 10/2007
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2010 - 04/2001
2	Encephalitis (Encephalitis, Rasmussen) 09/2007 - 06/2007
2	Graft vs Host Disease (Graft-Versus-Host Disease) 06/2007 - 03/2006
2	Virus Diseases (Viral Diseases) 06/2007 - 01/2005
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2006 - 08/2001
1	Febrile Neutropenia 02/2014
1	Multiple Myeloma 02/2014
1	Neutropenia 02/2014
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2008
1	Neuroinflammatory Diseases 10/2008
1	Neoplasm Metastasis (Metastasis) 10/2007
1	Viremia 09/2007
1	Brain Diseases (Brain Disorder) 06/2007
1	Leukocytosis (Pleocytosis) 06/2007
1	Hematologic Neoplasms (Hematological Malignancy) 06/2005
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 12/2004
1	Residual Neoplasm 01/2002
1	Epstein-Barr Virus Infections 01/2002
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2001
1	Metabolic Bone Diseases (Osteopenia) 03/2001
1	Congenital Abnormalities (Deformity) 03/2001
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2001
1	Osteogenesis Imperfecta (Lobstein Disease) 03/2001
1	Ewing Sarcoma (Sarcoma, Ewing) 12/2000
1	Rhabdomyosarcoma 12/2000
1	Vesicular Stomatitis 02/2000

Drug/Important Bio-Agent (IBA)

10	AntigensIBA 06/2013 - 12/2000
5	Cancer VaccinesIBA 03/2010 - 12/2000
4	Interleukin-2 (IL2)IBA 03/2010 - 12/2000
4	Monoclonal AntibodiesIBA 01/2009 - 02/2000
4	Proteins (Proteins, Gene)FDA Link 06/2007 - 02/2000
4	CytokinesIBA 01/2002 - 07/2000
3	Chimeric Antigen ReceptorsIBA 06/2013 - 10/2001
3	Pharmaceutical PreparationsIBA 03/2010 - 08/2001
3	CD40 Ligand (CD40L)IBA 03/2010 - 04/2001
3	Antiviral Agents (Antivirals)IBA 09/2007 - 11/2005
3	AntibodiesIBA 03/2006 - 12/2000
3	Peptides (Polypeptides)IBA 12/2004 - 04/2001
2	Interleukin-15 (Interleukin 15)IBA 06/2010 - 01/2003
2	CD19 AntigensIBA 06/2010 - 10/2006
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2009 - 12/2000
2	Interleukin-12 (IL 12)IBA 10/2007 - 01/2003
2	Viral DNAIBA 09/2007 - 06/2007
2	Alemtuzumab (Campath)FDA Link 06/2007 - 11/2005
2	Cytostatic AgentsIBA 02/2005 - 08/2001
2	ChemokinesIBA 01/2002 - 07/2000
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2014
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2014
1	AndrogensIBA 06/2013
1	Annexin A5IBA 06/2010
1	VaccinesIBA 01/2009
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 03/2006
1	PolylysineIBA 12/2004
1	dl1520 (ONYX-015)IBA 04/2004
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2003
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2002
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2002
1	EpitopesIBA 10/2001
1	GangliosidesIBA 10/2001
1	Complement System Proteins (Complement)IBA 08/2001
1	Immunoglobulin Idiotypes (Idiotype, Immunoglobulin)IBA 05/2001
1	Histocompatibility Antigens Class IIBA 04/2001
1	Collagen Type I (Type I Collagen)IBA 03/2001
1	Viral AntigensIBA 02/2001
1	Single-Chain AntibodiesIBA 12/2000
1	Rituximab (Mabthera)FDA Link 02/2000
1	Glycoproteins (Glycoprotein)IBA 02/2000

Therapy/Procedure

15	Therapeutics 06/2013 - 02/2000
6	Stem Cell Transplantation 09/2007 - 02/2000
5	Immunotherapy 06/2013 - 02/2001
3	Transplantation 02/2014 - 02/2001
3	Hematopoietic Stem Cell Transplantation 10/2008 - 03/2006
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2002 - 03/2001
1	Length of Stay 02/2014
1	Salvage Therapy 04/2010
1	Drug Therapy (Chemotherapy) 04/2010
1	Aftercare (After-Treatment) 10/2007
1	Intravenous Administration 04/2004